The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, Electro-Medical Equipment Research Division of KERI is underway smoothly.
KERI’s transcranial random noise stimulation shows promise for metabolic syndrome treatment
- Post author:
- Post published:August 12, 2024
- Post category:uncategorized